Big pharma companies object to change that would allow generic manufacture of protected medicines for markets outside the bloc
Mylan boss calls for waiver on manufacturing of biosimilars
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices